Published on 19 Mar 2024 on Insider Monkey via Yahoo Finance
Here’s Why Insulet (PODD) Detracted in Q4
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “ClearBridge Aggressive Growth Strategy” investor letter, which can be downloaded here. The strategy outperformed its Russell 3000 Growth Index benchmark for the quarter. It had delivered gains across seven of the eight sectors in which it was invested on an absolute basis. Overall stock selection contributed to the strategy's performance on a relative basis. In addition, please check the fund’s top five holdings to know its best picks in 2023.
ClearBridge Aggressive Growth Strategy featured stocks like Insulet Corporation (NASDAQ:PODD) in the fourth quarter 2023 investor letter. Headquartered in Acton, Massachusetts, Insulet Corporation (NASDAQ:PODD) develops and manufactures insulin delivery systems. On March 18, 2024, Insulet Corporation (NASDAQ:PODD) stock closed at $171.68 per share. One-month return of Insulet Corporation (NASDAQ:PODD) was -10.68%, and its shares lost 47.34% of their value over the last 52 weeks. Insulet Corporation (NASDAQ:PODD) has a market capitalization of $12.005 billion.
ClearBridge Aggressive Growth Strategy stated the following regarding Insulet Corporation (NASDAQ:PODD) in its fourth quarter 2023 investor letter: